Adma Biologics (ADMA) EBITDA Margin Growth (5y) (2016 - 2025)
Adma Biologics (ADMA) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
16,848.00 |
| Sep 30, 2025 |
17,230.00 |
| Jun 30, 2025 |
25,497.00 |
| Mar 31, 2025 |
19,480.00 |
| Dec 31, 2024 |
9,762.00 |
| Sep 30, 2024 |
15,838.00 |
| Jun 30, 2024 |
19,855.00 |
| Mar 31, 2024 |
40,098.00 |
| Dec 31, 2023 |
42,720.00 |
| Sep 30, 2023 |
33,391.00 |
| Jun 30, 2023 |
28,735.00 |
| Mar 31, 2023 |
40,759.00 |
| Dec 31, 2022 |
7,572.00 |
| Sep 30, 2022 |
28,239.00 |
| Jun 30, 2022 |
23,492.00 |
| Mar 31, 2022 |
17,493.00 |
| Dec 31, 2021 |
9,455.00 |
| Sep 30, 2021 |
5,739.00 |
| Jun 30, 2021 |
15,432.00 |
| Mar 31, 2021 |
10,131.00 |
